GCM Grosvenor Stock Quote GCMG - Stock Price, News, Charts, Message Board, Trades

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
GCM Grosvenor Inc (GCMG) Quote

GCM Grosvenor Inc (GCMG)

11.50

0.00

(0.00%)

Closed November 04 4:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

11.50

Bid

11.23

Ask

11.68

Volume

-

0.00 Day's Range 0.00

7.75 52 Week Range 11.90

Market Cap

Previous Close

11.50

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

164,568

Shares Outstanding

188,809,440

Dividend Yield

3.83%

PE Ratio

169.87

Earnings Per Share (EPS)

0.07

Revenue

445M

Net Profit

12.77M

GCM Grosvenor Inc is a global alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, and absolute return strategies. The company's offerings include multi-manager portfolios as w... GCM Grosvenor Inc is a global alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, and absolute return strategies. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments. It also offers multi-client portfolios for investors who desire a turn-key solution for accessing alternative investments. Show more

Sector

Investment Advice

Industry

Investment Advice

Website

www.gcmgrosvenor.com

Headquarters

Wilmington, Delaware, USA

Founded

-

GCM Grosvenor Inc is listed in the Investment Advice sector of the NASDAQ with ticker GCMG. The last closing price for GCM Grosvenor was $11.50. Over the last year, GCM Grosvenor shares have traded in a share price range of $ 7.75 to $ 11.90.

GCM Grosvenor currently has 188,809,440 shares outstanding. The market capitalization of GCM Grosvenor is $2.17 billion. GCM Grosvenor has a price to earnings ratio (PE ratio) of 169.87.

GCM Grosvenor to Announce Third Quarter 2024 Financial Results and Host Investor Conference Call on November 8, 2024

CHICAGO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced today that it will release its results for the third...

GCM Grosvenor’s Infrastructure Advantage Strategy Acquires Equity Interest in Brookfield’s Shepherds Flat

CHICAGO, Sept. 24, 2024 (GLOBE NEWSWIRE) -- GCM Grosvenor (NASDAQ: GCMG), a leading global alternative asset management firm, today announced that its Infrastructure Advantage Strategy has...

CION Investments and GCM Grosvenor Form Strategic Partnership Focused on Developing Private Market Investment Solutions

CION Investments (CION), a leading alternative investment solutions platform, and GCM Grosvenor, (NASDAQ: GCMG), a global alternative asset management firm, are pleased to announce a strategic...

Axxes Capital Launches Interval Fund to Provide Accredited Investors Access to the Private Equity Asset Class

CORAL GABLES, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Axxes Capital Inc. (together with its affiliates, “Axxes”), a private markets investment firm dedicated to providing wealth advisors and...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

GCM Grosvenor Reports Second Quarter 2024 Earnings Results

CHICAGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- GCM Grosvenor (Nasdaq: GCMG) today reported its results for the second quarter 2024, which have been posted to the Public Shareholders section of GCM...

GCM Grosvenor to Announce Second Quarter 2024 Financial Results and Host Investor Conference Call on August 8, 2024

CHICAGO, July 25, 2024 (GLOBE NEWSWIRE) -- GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced today that it will release its results for the second...

OlivePoint Welcomes GCM Grosvenor as a New Strategic Investor

GCM Grosvenor Commits $50 Million to OlivePoint’s Latest Investment Fund OlivePoint, a private real estate investor, today announced that GCM Grosvenor (Nasdaq: GCMG), a global alternative asset...

GCM Grosvenor to Present at the Morgan Stanley U.S. Financials and Payments Conference on June 12, 2024

CHICAGO, May 29, 2024 (GLOBE NEWSWIRE) -- GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced today that Jon Levin, President of GCM Grosvenor, will...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.11	-0.947459086994	11.61	11.83	11.47	130531	11.60285827	CS
4	0.15	1.32158590308	11.35	11.9	11.02	171429	11.54437645	CS
12	1.12	10.7899807322	10.38	11.9	10.04	164568	11.216386	CS
26	1.75	17.9487179487	9.75	11.9	9.25	169984	10.67635039	CS
52	3.06	36.2559241706	8.44	11.9	7.75	179185	9.70268742	CS
156	-0.18	-1.54109589041	11.68	12.38	6.26	223683	8.85166309	CS
260	0.8	7.47663551402	10.7	15.36	6.26	325674	10.23462443	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AALAmerican Airlines Group Inc	$ 13.54 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 64.14 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.99 (0.00%)	0
AACGATA Creativity Global	$ 1.01 (0.00%)	0
AALAmerican Airlines Group Inc	$ 13.54 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 64.14 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.99 (0.00%)	0
AACGATA Creativity Global	$ 1.01 (0.00%)	0
AALAmerican Airlines Group Inc	$ 13.54 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 64.14 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.99 (0.00%)	0
AACGATA Creativity Global	$ 1.01 (0.00%)	0

bernice

bernice 10 minutes ago

I think the reason is: something is behind the bush now and not in September.

JamesLH

JamesLH 12 minutes ago

Little Ricki crying yet again that he can't stop the whistle-blowers from exposing this FRAUD. Why don't you go make the same fake police report you conman CEO Nick Campanella claims he did?

Let's see how quickly you get laughed and thrown out of the police station! LMFAO

marcis

marcis 19 minutes ago

No, here is ok but, admittedly spinning BS, without owning is, plain wrong.

The gap off an outdated irrelevant chart before the merger announcement

You cannot show RDAR is in default

And this upper level people you refer to is hilariously not here or sh

tkg

tkg 20 minutes ago

The growth of data center CapEx is expected to be driven by the deployment of new data centers by cloud, colocation, and telco service providers, as well as enterprise data center modernization. Some predict that data center CapEx could top $1 trillion by 2027 due to the growth of artificial intelli

cottonisking

cottonisking 20 minutes ago

🌍️🌍️🗺️ This World is all jacked up right now! UNBELIEVABLE, it only took him four years.

wagner

wagner 20 minutes ago

Might someone have an idea?

The new money infussion is used to pay Marks loan 2 million back

Why not in September taken the placement?

Mark gets money, anyway

either way too stupid or unable to plan

sharing4u

sharing4u 23 minutes ago

style="font-size: 16px"Here are the top 7 partnerships and joint ventures of JP3E:
style="font-size: 16px"

style="font-size: 16px"*US Partnerships*
style="font-size: 16px"

style="font-size: 16px"1. *JP3E ExxonMobil Energy Partners*

snow

snow 25 minutes ago

I ll be back Your statements are very dubious. I have found the following googling MOU: "Our partners often ask us to explain the difference
between a contract and a memorandum of
understanding (MOU). Although there can be legal
distinctions between the two types of documents,

DocLee

DocLee 34 minutes ago

Droid - You really are an infantile Wally trying that hopeless line of argument.

sharing4u

sharing4u 37 minutes ago

style="font-size: 16px"Here are the details relating to JP3E and ArcLight Capital Partners joint ventures:
style="font-size: 16px"

style="font-size: 16px"*JP3E Energy Partners LLC*
style="font-size: 16px"

style="font-size: 16px"- In

Ribo

Ribo 39 minutes ago

$IDVV Change in Control
https://www.otcmarkets.com/otcapi/company/financial-report/414724/content

sharing4u

sharing4u 40 minutes ago

Focus seeking help from AI search was not on accuracy but for a general vscope about business coverage and foot print in US and worldwide.
How big how wide is JP3E ?

Batman412

Batman412 42 minutes ago

Big buys coming all week mark it

sharing4u

sharing4u 50 minutes ago

This is trying to answer the following questions:

A. Any affiliation or partnership between JP3E (JP 3E Holdings Inc.) and ArcLight Capital Partners ?

B. How BIG is JP3E relating to US and global style="font-size: 1em"business ?

Believe it or not.

dennisdave

dennisdave 51 minutes ago

mmmmm

DCVAXL trial
Median OS (mOS) for the 232 patients with nGBM receiving DCVax-L was 19.3 (95% CI, 17.5-21.3) months

SurVaxM is an experimental vaccine for the treatment of brain tumors. Early results from a small trial were recently reported Of 63 patients

GVInvestments

GVInvestments 57 minutes ago

How until they Hit $300 per share? I really want 300 per share.

Truthsocial

Truthsocial 1 hour ago

You are hitting the nail right on the head spot on ...facts are facts
Seems most so called Conspiracy theories have come to be true Facts...that's a Fact

misterfishman

misterfishman 1 hour ago

I kid you not i. Can still bench 225 because of it.your going to want to take Dimm with it to block estrogen cause it will increase that as well.

PC retired

PC retired 1 hour ago

Dania?, do you mean Denmark?

go seek

go seek 1 hour ago

Judge Denise J.Casper is the judge on the Paxlovid lawsuit. Her husband is Marc Casper, CEO of Thermo Fisher Scientific.
Goggle ‘Thermo Fisher Scientific Pfizer’… There could be a conflict of interest here.

Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access t

TheOTCstocksGuy

TheOTCstocksGuy 1 hour ago

Headed under .50 and lower! Watch and learn...

rx7171

rx7171 1 hour ago

Since sleep improvement is neither a primary or secondary trial endpoint we should not expect precise data with a p value.

Hoghead7

Hoghead7 1 hour ago

Check this out!
https://www.linkedin.com/posts/mark-labarbera-4230924a_working-closely-with-our-partners-at-toyota-activity-7244686263331557377-I8YD?utm_source=share&utm_medium=member_android

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions